Capital Analysts LLC’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2K Hold
49
﹤0.01% 1316
2025
Q1
$2K Hold
49
﹤0.01% 1303
2024
Q4
$2K Hold
49
﹤0.01% 1217
2024
Q3
$2K Hold
49
﹤0.01% 1208
2024
Q2
$3K Hold
49
﹤0.01% 1078
2024
Q1
$3K Buy
+49
New +$3K ﹤0.01% 1014